AlphaStocks

DVA vs VCYT

As of Sep 20, 2026, Davita (DVA) scores 7.0/10 and Veracyte (VCYT) 5.3/10 on AlphaStocks' five-model composite, so DVA scores higher. DVA trades 29% below its model fair value; VCYT trades 104% above its model fair value.

DVA

DAVITA INC.

7.0

Consider Buy

$183.88

VCYT

VERACYTE, INC.

5.3

Consider Buy

$39.78

DVA vs VCYT: Which is the Better Investment?

DAVITA INC. (DVA) scores 7.0/10 while VERACYTE, INC. (VCYT) scores 5.3/10 on AlphaStocks' composite model. DAVITA INC. has the higher composite rating of Consider Buy. On a P/E basis, DAVITA INC. trades at 12.9x, making it the more attractively priced of the two. DAVITA INC. trades further below its estimated fair value.

This comparison is algorithmically generated and is not financial advice.

MetricDVAVCYT
Scores & Fundamentals
Composite Score7.0/105.3/10
RatingConsider BuyConsider Buy
Price$183.88$39.78
P/E Ratio12.948.3
ROE-176.4%3.9%
Market Cap$13B$3B
Fair Value$260.62$19.52
Dividend Yield
Sector Rank#14 of 168#90 of 168
Model Verdicts
PiotroskiAttractiveStrong
BuffettAttractiveNeutral
GrahamNeutralCaution
LynchNeutralLimited Data
GreenblattAttractiveLimited Data
View full DVAanalysis →View full VCYTanalysis →

Related comparisons

Compare any two stocks →

DVA vs VCYT: Which Stock Scores Higher?

DAVITA INC. (DVA) and VERACYTE, INC. (VCYT) are both in the Health Care sector. DVA currently leads with a composite score of 7.0/10 (Consider Buy) compared to VCYT's 5.3/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer